Back
Day Range
$57.52
$62.81
52-Week Range
$9.57
$76.76
Volume
2,732,341
50D / 200D Avg
$63.61
/
$41.41
Prev Close
$56.27
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (631 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -5217.5 | 0.2 |
| P/B | 18.3 | 3.0 |
| ROE % | -0.5 | 3.6 |
| Net Margin % | -0.2 | 3.8 |
| Rev Growth 5Y % | 56.5 | 9.9 |
| D/E | 0.8 | 0.2 |
Analyst Price Target
Hold
$78.78
+29.6%
Low: $35.00
High: $110.00
Forward EPS
-$3.21
Est. Revenue
454.26M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$3.01
$1.52 – $4.65
|
1.62B | 5 |
| FY2029 |
-$1.27
-$1.96 – -$0.64
|
886.47M | 2 |
| FY2028 |
-$2.81
-$4.10 – -$1.10
|
548.60M | 7 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-05 | $0.04 | $0.22 | +491.9% |
| 2025-11-25 | -$0.11 | -$0.18 | -61.3% |
| 2025-08-07 | -$0.94 | -$1.26 | -34.0% |
| 2025-05-12 | -$0.06 | $2.75 | +4683.3% |
| 2025-02-10 | -$0.42 | -$1.39 | -231.0% |
| 2024-11-26 | -$1.05 | -$1.38 | -31.4% |
| 2024-08-08 | -$0.58 | -$1.38 | -137.9% |
| 2024-05-09 | -$0.06 | -$1.02 | -1600.0% |
Dividend History
Yield
0.00%
Payout Ratio
0.00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Key Takeaways
Revenue grew 56.50% annually over 5 years — strong growth
Generating 156.89M in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 23201.65%
Capital efficient — spends only 2.73% of revenue on capex
Interest coverage of 1.10× — tight debt servicing
Growth
Revenue Growth (5Y)
56.50%
Revenue (1Y)23258.15%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-0.50%
ROIC8.86%
Net Margin-0.20%
Op. Margin11.86%
Safety
Debt / Equity
0.79
Current Ratio4.86
Interest Coverage1.10
Valuation
P/E Ratio
-5217.51
Forward P/EN/A
P/B Ratio18.26
EV/EBITDA87.95
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 23258.15% | Revenue Growth (3Y) | 85.62% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 56.50% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 829.45M | Net Income (TTM) | -1.63M |
| ROE | -0.50% | ROA | -0.12% |
| Gross Margin | 97.12% | Operating Margin | 11.86% |
| Net Margin | -0.20% | Free Cash Flow (TTM) | 156.89M |
| ROIC | 8.86% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.79 | Current Ratio | 4.86 |
| Interest Coverage | 1.10 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | 0.00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -5217.51 | Forward P/E | N/A |
| P/B Ratio | 18.26 | P/S Ratio | 10.26 |
| PEG Ratio | 28.35 | Forward PEG | N/A |
| EV/EBITDA | 87.95 | Fwd EV/EBITDA | N/A |
| Forward P/S | 18.73 | Fwd Earnings Yield | N/A |
| FCF Yield | 1.84% | ||
| Market Cap | 8.51B | Enterprise Value | 8.65B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 829.45M | 3.55M | 240.74M | 243.23M | 138.29M |
| Net Income | -1.63M | -599.49M | -205.28M | -176.06M | -140.85M |
| EPS (Diluted) | -0.01 | -5.00 | -1.92 | -1.67 | -1.36 |
| Gross Profit | 805.52M | 3.55M | 240.74M | 243.23M | 138.29M |
| Operating Income | 98.35M | -601.08M | -205.00M | -178.51M | -149.04M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.39B | 1.14B | 765.55M | 691.94M | 710.15M |
| Total Liabilities | 881.88M | 948.74M | 478.39M | 273.60M | 301.33M |
| Shareholders' Equity | 466.05M | 185.44M | 271.34M | 398.52M | 408.82M |
| Total Debt | 366.28M | 851.91M | 383.50M | 81.58M | 25.55M |
| Cash & Equivalents | 226.55M | 102.69M | 110.89M | 108.01M | 184.43M |
| Current Assets | 950.64M | 695.47M | 419.52M | 405.30M | 384.60M |
| Current Liabilities | 195.49M | 103.17M | 105.46M | 138.85M | 146.54M |